Notice of annual general meeting in CellaVision AB (publ), April 23 2008

2008-03-26 - English

The notice is available in Swedish only, please see the link below.
 
For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 46-286 44 00. E-mail: yvonne.martensson@cellavision.com
Johan Wennerholm, CFO, CellaVision AB
Phone: +46 46-286 44 00. E-mail: johan.wennerholm@cellavision.com
 
About CellaVision
CellaVision AB develops, markets, and sells the market leading image analysis based systems for routine analysis of blood and other body fluids. The company has a core competence in development of software for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company's associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy.
 
The company headquarters are in Lund, Sweden and has subsidiaries in Jupiter, FL, USA, and Toronto, ON, Canada. For more information, visit www.cellavision.com.
 
CellaVision's share is listed on First North at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.

PDF version: Notice of annual general meeting in CellaVision AB (in Swedish)

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analyst

ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93

Pareto Securities AB
Christian Lee
+46 8 402 52 67

 

Access our Student Resources

To access this resource, please provide the following information about yourself.